Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera - Muik, Alexander; Wallisch, Ann-Kathrin; Sänger, Bianca; Swanson, Kena A.; Mühl, Julia; Chen, Wei; Cai, Hui; Maurus, Daniel; Sarkar, Ritu; Türeci, Özlem; Dormitzer, Philip R.; Şahin, Uğur (Science (American Association for the Advancement of Science), 2021)
Keywords: Adult; Aged; Amino acid sequence; Amino acids; Antibodies; Antibodies, Neutralizing - blood; Antibodies, Viral - blood; Antisera; China; Coronaviridae; Coronaviruses; COVID-19; COVID-19 - blood; COVID-19 - prevention & control; COVID-19 - virology; COVID-19 vaccines; COVID-19 Vaccines - immunology; Female; Humans; Immunization; Infectivity; Male; Medicine; Microbio; Middle Aged; mRNA; Mutation; Neutralization; Neutralization Tests; Neutralizing; Proteins; Respiratory diseases; SARS-CoV-2 - genetics; SARS-CoV-2 - immunology; Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus - genetics; Spike Glycoprotein, Coronavirus - immunology; Spike protein; United Kingdom; Vaccines; Young Adult; United Kingdom; China; United Kingdom--UK